Population
Laboratories participating in an External Quality Assessment program in Germany, Belgium, and the Netherlands
Design
Other
Follow-up
Throughout 2015
Authors
Loading...
Supports multinational HbA1c EQA feasibility with fresh blood; leaves open manufacturer-specific standardization needs pending prospective trials.
An accuracy-based EQA program for HbA1c using fresh whole blood is logistically feasible across multiple countries and shows that assay quality is primarily manufacturer-related.
Kaiser et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: